本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atara Biotherapeutics

7.60
+0.700010.14%
盘后7.800.2000+2.63%17:30 EDT
成交量:5.67万
成交额:42.18万
市值:4,452.77万
市盈率:-0.67
高:7.76
开:6.97
低:6.94
收:6.90
数据加载中...

公司资料

公司名字:
Atara Biotherapeutics
交易所:
NASDAQ
成立时间:
2012
员工人数:
153
公司地址:
1280 Rancho Conejo Blvd,Thousand Oaks,California,United States
邮编:
91320
电话:
传真:
- -
简介:
Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。该公司是T细胞免疫疗法的领导者,利用其新型同种异体EB病毒(EBV)T细胞平台为癌症和自身免疫性疾病患者开发转化疗法。

董事

名称
职位
Pascal Touchon
Director,President and Chief Executive Officer
Ronald C. Renaud, Jr.
Chair of the Board
Ameet Mallik
Director
Beth Seidenberg
Director
Carol Gallagher
Director
Eric L. Dobmeier
Director
Maria Grazia Roncarolo
Director
Matthew K. Fust
Director
Roy Baynes
Director
William Heiden
Director

股东

名称
职位
Pascal Touchon
Director,President and Chief Executive Officer
Amar Murugan
Senior Vice President, General Counsel
Kristin Yarema
Senior Vice President, Chief Commercial Officer
Utpal Koppikar
Executive Vice President, Chief Financial Officer
Jakob Dupont
Executive Vice President, Global Head of Research and Development